189 results
Page 5 of 10
8-K
EX-99.2
c8qziia aq1r6
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
4v4aawl9
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
3z7qca 4t0nkr
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.1
lvpt9oe
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-99.1
n4p0h88 423
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.3
hpwgj
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.4
x0ya1mugqcddvqh8j
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.2
tuni32lp5jy0f mv04n
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
49t4yzj1kvx
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
k7nwfqpg0rgwe 75
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
ukqpcgtftoluhwv59tnu
24 Jun 20
Business combination disclosure
5:11pm
8-K
8ly6wpeq37rgy2e
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.2
m3aizg
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm